Position
Quantbot Technologies LP in Halozyme Therapeutics, Inc.
Back to the book · All holders of HALO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$8.78K$67.30 → $64.63
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 4.25K | $286.2K | — | — | — | 0.0% |
| Q1 2026 | 3.29K | $212.5K | $64.63 | −$8.78K | −$64.9K | 0.0% |